ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,297.10
-0.21%
Dow Jones
39,869.38
-0.10%
US Dollar vs MXN
16.7116
0.19%
Brent Oil
83.365
0.19%
Bitcoin
65,601.48
0.56%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. PDL BioPharma Inc (PDLI)

  7. PDL BioPharma Inc (PDLI) Noticias

PDLI

PDL BioPharma (PDLI)

PDL BioPharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PDLI
FechaHoraFuenteTítuloSímboloCompañía
10/02/202313:45Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NASDAQ:PDLIPDL BioPharma Inc
08/02/202214:56Edgar (US Regulatory)Schedule 13gNASDAQ:PDLIPDL BioPharma Inc
29/03/202105:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PDLIPDL BioPharma Inc
11/02/202105:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PDLIPDL BioPharma Inc
04/02/202105:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PDLIPDL BioPharma Inc
03/02/202116:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PDLIPDL BioPharma Inc
02/02/202115:21Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PDLIPDL BioPharma Inc
11/01/202116:28Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PDLIPDL BioPharma Inc
11/01/202115:33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PDLIPDL BioPharma Inc
28/12/202015:14Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...NASDAQ:PDLIPDL BioPharma Inc
16/12/202005:05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PDLIPDL BioPharma Inc
14/12/202007:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PDLIPDL BioPharma Inc
14/12/202007:30PR Newswire (US)PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Anno...NASDAQ:PDLIPDL BioPharma Inc
08/12/202015:05PR Newswire (US)PDL Announces Timeline for Voluntarily Delisting from NasdaqNASDAQ:PDLIPDL BioPharma Inc
11/11/202015:05PR Newswire (US)PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets Date To File a Certificate of DissolutionNASDAQ:PDLIPDL BioPharma Inc
09/11/202016:09Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PDLIPDL BioPharma Inc
06/11/202016:26PR Newswire (US)PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business UpdateNASDAQ:PDLIPDL BioPharma Inc
29/10/202007:00PR Newswire (US)PDL BioPharma to Announce Third Quarter 2020 Financial Results and Provide a Business Update on November 9, 2020NASDAQ:PDLIPDL BioPharma Inc
05/10/202015:34Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:PDLIPDL BioPharma Inc
02/10/202007:30PR Newswire (US)PDL BioPharma Completes Spin-Off of LENSARNASDAQ:PDLIPDL BioPharma Inc
10/09/202007:30PR Newswire (US)PDL BioPharma to Complete Spin-Off of LENSAR, Inc. on October 1, 2020NASDAQ:PDLIPDL BioPharma Inc
09/09/202007:30PR Newswire (US)PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley CapitalNASDAQ:PDLIPDL BioPharma Inc
31/08/202008:00PR Newswire (US)PDL BioPharma Announces Sale of Kybella®, Zalviso® and Coflex® Royalties to SWK Holdings CorporationNASDAQ:PDLIPDL BioPharma Inc
28/08/202007:42Edgar (US Regulatory)Tender Offer Statement by Issuer (sc To-i)NASDAQ:PDLIPDL BioPharma Inc
28/08/202007:30PR Newswire (US)PDL BioPharma Announces Offer to Purchase Convertible Notes Due 2021 and 2024NASDAQ:PDLIPDL BioPharma Inc
26/08/202008:00PR Newswire (US)PDL BioPharma Announces Filing of a Form 10 Registration Statement with the Securities and Exchange Commission for a Potentia...NASDAQ:PDLIPDL BioPharma Inc
12/08/202007:30PR Newswire (US)PDL BioPharma Enters Into Settlement Agreement with WellstatNASDAQ:PDLIPDL BioPharma Inc
06/08/202015:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PDLIPDL BioPharma Inc
06/08/202015:05PR Newswire (US)PDL BioPharma Reports 2020 Second Quarter Financial ResultsNASDAQ:PDLIPDL BioPharma Inc
30/07/202015:05PR Newswire (US)PDL BioPharma to Announce Second Quarter 2020 Financial Results on August 6, 2020NASDAQ:PDLIPDL BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:PDLI

Su Consulta Reciente

LSE
ENNR
MRTX
TCHETH
ThoreCash
COIN
LIBREETH
Libre
DBI
3BVV
DAX 50 ESG EUR PR
NASDAQ
AAZXYXX
Bofa Finance Llc Issuer ...
COIN
JAREDUST
Jared From Subway
HITB
QNTUSDT
Quant
AQSE
UNX
Unigel
ASX
BNZ
Benz Mining
EU
R678S
R678S
NASDAQ
AAYPEXX
Bank of Montreal Autocal...
LSE
0HAO
NASDAQ
MCAGU
Mountain Crest Acquisiti...
ASX
WEFHE
Westfield UK and Europe ...
USOTC
PPEVD
Olivier Ventures (CE)
BIBX
SHONUSDT
ShonToken
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados